Search
for
Sort by
Research 541–570 of 1000+
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Polyglutamate: Unleashing the Versatility of a Biopolymer for Cosmetic Industry Applications
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- Deciphering of Anti-Alopecia Activity of Polyphenol from Beta vulgaris Root against 5α-reductase: Molecular Insight
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
- NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
- Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
- Glabellar clinical and trichoscopic findings in patients with frontal fibrosing alopecia
- Early androgen activity after birth determines the hypothalamic expression of androgen and estrogen receptors in adulthood in female but not in male rats
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats
- Terapia antiandrogénica como quimioprevención del cáncer de próstata
- The medicinal activity of lyophilized aqueous seed extract of Lepidium sativum L. in an androgenic alopecia model
- Drugs Affecting Hair Growth
- Stauntonia hexaphylla Extract Ameliorates Androgenic Alopecia by Inhibiting Androgen Signaling in Testosterone-induced Alopecia Mice
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review